# Anteris Technologies Global Corp. (AVR) · Edgar & Edgarette company card

> Anteris Technologies Global (AVR) saw revenue fall 29.2% in FY2025 to $2 million, operating margin -4908% against a 11.0% median for orthopedic, prosthetic & surgical appliances & supplies, equity -0.4% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 2011514 · fiscal year ended 2025-12-31 · 2 audited years read · [page](https://www.pops4.com/boards/company/AVR) · [JSON](https://www.pops4.com/boards/company/AVR.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $2M |
| Revenue growth, 1 year | -29.2% |
| Revenue growth per year | — |
| Operating margin | -4908.2% (prior year -2899.4%) |
| Net margin | -4925.5% |
| Operating cash flow | −$78M |
| Capital spending | $2M |
| Free cash flow | −$80M |
| Cash | $13M |
| Long-term debt | $38,000 |
| Total assets | $23M |
| Total equity | −$93,000 |
| Equity ÷ assets | -0.4% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -81.59 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Beneish M: -6.3 (below the −1.78 line)
- Health Harbor boat: Rotting at the dock · four or more warning signs · liabilities exceed assets (often from years of share buybacks, not always distress); operating cash flow was negative; operating loss: a margin of -4908.2% in FY2025; revenue is hard to predict: its 80% range is ±28%

## Edgarette's reading

Exposure: revenue $1.9M (FY2025), total debt $38K. Experience: revenue down 29.2% on the year; operating margin -4908.2%, down from -2899.4%. Soundness: equity -0.4% of assets (liabilities exceed assets). Credibility: 2 audited years, moderate weight. Range: 80% of past cases like this landed between $994K and $1.8M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, orthopedic, prosthetic & surgical appliances & supplies): operating margin -4908.2% against a 11.0% median; growth -29.2% against 7.5%.

Range logged 2026-09-20, receipt 70ca72aaf09f49a2, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-09-17 ([filing](https://www.sec.gov/Archives/edgar/data/2011514/000114036126037002/0001140361-26-037002-index.htm))

## Recent filings

- 8-K · filed 2026-09-23 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2011514/000114036126037392/0001140361-26-037392-index.htm)
- 8-K · filed 2026-09-17 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/2011514/000114036126037002/0001140361-26-037002-index.htm)
- 8-K · filed 2026-09-08 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2011514/000114036126035840/0001140361-26-035840-index.htm)
- 8-K · filed 2026-08-12 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2011514/000114036126032296/0001140361-26-032296-index.htm)
- 10-Q · filed 2026-08-11 · [filing](https://www.sec.gov/Archives/edgar/data/2011514/000114036126032232/0001140361-26-032232-index.htm)
- 8-K · filed 2026-08-03 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2011514/000114036126030586/0001140361-26-030586-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0002011514.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2011514

## Cite

POPS4, Edgar & Edgarette: Anteris Technologies Global Corp. (AVR) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/AVR. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.